About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 290 record(s)
Req # A-2022-09061
Copy of the resignation letter of the Vice-Chair Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
January 2023
Req # A-2021-10764
Copies of all emails to/from/cc'ing all Directors from May 31, 2021 to June 4, 2021.Organization: Patented Medicine Prices Review Board Canada
December 2022
Req # A-2022-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th. So this request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well.Organization: Patented Medicine Prices Review Board Canada
December 2022
Nothing to report this month
Organization: Canadian Human Rights Commission
Req # A-2022-00009
Request to provide records related to the introduction of gender identity as a ground of discrimination to the Canadian Human Rights Act. More specifically, the requester sought records regarding who made the decision to add this ground, did the Commission consult with the sport community in Canada and whether it considered what impacts this would have on the sport community.Organization: Canadian Human Rights Commission
November 2022
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-00008
Request to provide the following briefing notes: - BN to the CC - Memorandum - Annual Reporting to the Public Service Commission (PSC) for the fiscal year 2020-2021; - Approval of the Quarterly Financial Report for the quarter ended December 31, 2020; - BN to CC - Signature of the 2020-21 Letter of Representation.Organization: Canadian Human Rights Commission
October 2022
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2020-00042
Request to provide records related to employment equity at the Canadian Human Rights Commission (CHRC) from 2010 to 2021 including reports, statistical data, communications and/or lists related to the following: - The development of the Anti-racism action plan and the Race based pilot project; - The consultant’s report (Mark Hart) on the race based pilot project; - A workplace assessment conducted by Mary Eberts in or around 2002 regarding the working environment for women at the CHRC; - Trainings, workshops, sensitivity or cultural competency events on anti-Black racism; - List of experts that have provided advice to the CHRC on anti-Black racism and systemic racial discrimination; - The activities and proactive measures that the CHRC has undertaken publicly to promote and recognize the UN International Decade for Peoples of African Descent; - The observations presented by Arleen Huggins to the CHRC on December 15, 2020 and the outcome of the facilitation exercise conducted by Arleen Huggins.Organization: Canadian Human Rights Commission
September 2022
Req # A-2022-01918
Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.Organization: Patented Medicine Prices Review Board Canada
September 2022